Table 14.
N (%) | |
---|---|
Selective serotonin reuptake inhibitors (SSRIs) | 381 (38.2) |
Sertraline | 126 (12.7) |
Fluoxetine | 99 (9.9) |
Escitalopram | 74 (7.4) |
Citalopram | 55 (5.5) |
Paroxetine | 22 (2.2) |
Fluvoxamine | 5 (0.5) |
Other antidepressants | 369 (37.0) |
Bupropion | 213 (21.4) |
Trazodone | 127 (12.8) |
Mirtazapine | 19 (1.9) |
Antidepressant unspecified | 7 (0.7) |
Miscellaneousa | < 5 (< 0.5) |
Tricyclic antidepressants (TCAs) | 117 (11.7) |
Amitriptyline | 84 (8.4) |
Nortriptyline | 16 (1.6) |
Doxepin | 13 (1.3) |
Miscellaneousb | < 5 (< 0.5) |
Serotonin-norepinephrine reuptake inhibitors (SNRIs) | 128 (12.9) |
Venlafaxine | 78 (7.8) |
Duloxetine | 41 (4.1) |
Desvenlafaxine | 7 (0.7) |
Miscellaneousc | < 5 (< 0.5) |
Monoamine oxidase inhibitor (MAOIs) | 1 (0.1) |
Phenelzine | 1 (0.1) |
Class total | 996 (100) |
aIncludes vortioxetine and tranylcypromine
bIncludes protriptyline, clomipramine, desipramine, and noxiptiline
cIncludes milnacipran and levomilnacipran